title: AML1/ETO and POU4F1 synergy drives B-lymphoid gene expression typical of t(8;21) acute myeloid leukemia.
authors: J
authors: J
authors: Dunne
authors: D
authors: D
authors: Mannari
authors: T
authors: T
authors: Farzaneh
authors: A
authors: A
authors: Gessner
authors: F W
authors: FW
authors: van Delft
authors: O
authors: O
authors: Heidenreich
authors: B D
authors: BD
authors: Young
authors: D M
authors: DM
authors: Gascoyne
mesh_terms: D001402:B-Lymphocytes / Q000378:metabolism*; D002891:Chromosomes, Human, Pair 21; D002898:Chromosomes, Human, Pair 8; D050676:Core Binding Factor Alpha 2 Subunit / Q000235:genetics*; D015870:Gene Expression; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics*; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D000075142:RUNX1 Translocation Partner 1 Protein; D050819:Transcription Factor Brn-3A / Q000235:genetics*; D014178:Translocation, Genetic
chemical_list: C107844:AML1-ETO fusion protein, human; D050676:Core Binding Factor Alpha 2 Subunit; D015514:Oncogene Proteins, Fusion; C494188:POU4F1 protein, human; D000075142:RUNX1 Translocation Partner 1 Protein; D050819:Transcription Factor Brn-3A